I-Function
I-Function is a Miami-based digital health company offering cloud-based cognitive assessment (LASSI-D) and functional skills training (FUNSAT) tools for healthcare providers, managed care plans, and clinical researchers focused on early Alzheimer's detection.
- Company typePrivate
- Founded2016
- HeadquartersMiami, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What I-Function does
I-Function, Inc. is a privately held digital health company founded in 2016 and headquartered in Miami, Florida. The company develops cloud-based software tools for cognitive assessment and functional skills training, serving healthcare providers, managed care organizations, and clinical researchers. Its portfolio centers on two commercial products: LASSI-D, a 15-minute self-administered digital cognitive assessment that uses an AI avatar guide to detect early memory impairment associated with Alzheimer's disease; and FUNSAT, a 6-module interactive platform that evaluates and trains everyday functional skills such as online banking, medication management, and transportation. The platform is delivered via web browsers on computers and tablets, requires no specialized equipment, and is available in English and Spanish. The company has a research-driven product foundation, with tools validated across 4,000+ individuals in NIH-supported studies and an extensive peer-reviewed publication record in journals including Alzheimer's and Dementia, Journal of Alzheimer's Disease, and American Journal of Geriatric Psychiatry.
I-Function firmographics
Firmographics- Name
- I-Function
- Legal name
- i-Function, Inc.
- Website
- https://i-function.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- I-Function is a Miami-based digital health company offering cloud-based cognitive assessment (LASSI-D) and functional skills training (FUNSAT) tools for healthcare providers, managed care plans, and clinical researchers focused on early Alzheimer's detection.
- Ownership category
- akta.pro rank
I-Function industry classification
Industry- Product category
- Digital Cognitive Assessment Software
- NAICS
- Educational Support Services (61171), Educational Support Services (611710)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- Intelligent Practice & Mastery Learning Platforms (Spaced Repetition, Skill Drills) (EDAFAFAD), Digital Learning Content Development (eLearning, Labs, Simulations) (BPAEANAD)
Keywords
Where I-Function is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
I-Function business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Assessment Licensing - LASSI-D: Organization purchases assessments at quantity-based pricing tiers. Standard tier for U.S. organizations up to 500 assessments; custom pricing for 500+ assessments or non-U.S. organizations.
- Training Platform Licensing - FUNSAT: Subscription or usage-based licensing for access to functional skills training platform. Programs typically last 6-12 weeks with 1-2 weekly training sessions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Standard pricing for U.S. organizations purchasing up to 500 assessments |
| Subscription | Multi-year contract | Custom pricing for large organizations or non-U.S. purchasers |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
I-Function product offering
Product offeringCore offering
I-Function develops and sells cloud-based digital cognitive assessment and functional skills training software for the healthcare market. Its two principal commercial products are LASSI-D, a 15-minute self-administered digital cognitive assessment with AI avatar guidance for early detection of memory impairment associated with Alzheimer's disease, and FUNSAT, a 6-module interactive platform that evaluates and trains everyday functional skills such as online banking, medication management, and transportation.
Product overview
I-Function offers a platform of cognitive and functional skills assessment and training tools. The portfolio consists of two primary commercial products: LASSI-D™ (a brief self-administered digital cognitive assessment for early Alzheimer's detection) and FUNSAT™ (a functional skills assessment and training platform covering everyday technology-based tasks). Related research products include LASSI-L™ (paper-based version) and LASSI-BC™ (computerized research version). These products share NIH-supported validation research and target healthcare providers, managed care organizations, and clinical researchers focused on cognitive health.
Differentiator
Problem solved
Functional benefit
Brands
- LASSI-D™: A clinically validated 15-minute digital cognitive assessment for detecting early memory impairment and cognitive changes associated with Alzheimer's disease
- FUNSAT™
Products and services
- LASSI-D A clinically validated 15-minute self-administered digital cognitive assessment with AI avatar guidance that identifies early memory impairment and cognitive changes associated with Alzheimer's disease in people at increased risk, reporting approximately 90% specificity and 80% accuracy, automated scoring, care plan recommendations, and provider alerts. Sold to healthcare organizations for use with patients/members, available in English and Spanish, and delivered cloud-based on computers and tablets.
- FUNSAT An interactive 6-module platform that evaluates and trains essential everyday functional skills including online banking, ATM banking, metro ticket kiosk, phone prescription refill, online pharmacy shopping, medication label comprehension, and medication organizer, with documented 50-200% increases in real-world skill use and 89-97% increases in medication management ability. Targeted at healthcare providers serving individuals who need to maintain or recover independence, including stroke survivors and people with cognitive impairment.
- LASSI-L The original paper-based LASSI cognitive challenge test developed at the University of Miami Miller School of Medicine, designed to measure proactive semantic interference and detect early cognitive decline associated with Alzheimer's disease, used as the research foundation underlying LASSI-D.
- LASSI-BC Initial research-focused computerized version of the LASSI-L test, providing standardized digital administration suitable for remote assessment with automated scoring.
Quantifiable outcome
- 98% of LASSI-D assessment users completed their self-administered cognitive assessment
- +6 more outcomes
Companies that use I-Function
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles4 records
I-Function technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature4 records
I-Function partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- University of Miami Miller School of MedicinecoreFounders Dr. Rosie Curiel, Dr. David Loewenstein, and Dr. Elizabeth Crocco are faculty members at University of Miami Miller School of Medicine. Research collaboration for development and validation of cognitive assessment tools. Company operates from Converge Miami (formerly UM Life Sciences and Technology Park).
- NIH (National Institutes of Health)coreResearch supported by NIH grants. Both LASSI-D and FUNSAT research validated in NIH-supported studies. Featured in 2024 NIH Alzheimer's and Related Dementias Research Progress Report.
- Center for Cognitive Neuroscience and Aging (CNSA)coreAffiliated research center at University of Miami where founders conduct research. Dr. David Loewenstein serves as Director of CNSA.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
I-Function competitors and assessment
Company assessmentDirect peers
- BrainCheck: BrainCheck offers a digital cognitive assessment and care planning platform used by health systems, physicians, and clinical trials. Directly comparable to LASSI-D in providing rapid, tablet-based cognitive screening with reimbursement-aligned workflows.
- Cognivue: Cognivue has developed FDA-cleared digital cognitive assessment devices focused on early detection of memory impairment and dementia. Directly comparable to LASSI-D in the cognitive screening category, with stronger regulatory positioning but more specialized hardware requirements.
- Cambridge Cognition: Cambridge Cognition provides digital cognitive testing solutions including the CANTAB battery, serving pharmaceutical clinical trials and healthcare providers. Comparable to I-Function in serving both clinical trial/research markets and enterprise healthcare with validated cognitive assessments.
- Cogstate: Cogstate provides computerized cognitive testing primarily for clinical trials in Alzheimer's and other CNS indications. Directly comparable to I-Function's pharma/CRO segment and LASSI-L/LASSI-BC research variants.
- Neurotrack: Neurotrack offers digital cognitive health assessments and lifestyle interventions focused on memory and Alzheimer's risk. Directly comparable in targeting early cognitive decline detection with self-administered digital tools.
- Posit Science (BrainHQ): Posit Science develops BrainHQ, a cognitive training platform with clinically validated exercises for memory, attention, and processing speed. Comparable to FUNSAT in delivering structured cognitive and functional skill training with documented clinical outcomes.
Emerging players
- Linus Health: Linus Health combines digital cognitive assessments (including the DCTclock) with brain health analytics for early Alzheimer's detection. Comparable to LASSI-D as a digital-first cognitive assessment, with focus on primary care and health system integration.
- Altoida: Altoida develops digital biomarkers and cognitive assessment tools using augmented reality and AI for early Alzheimer's prediction. Comparable to I-Function in targeting early cognitive impairment detection with novel digital approaches and pharma/CRO partnerships.
- Savonix: Savonix offers a mobile cognitive assessment platform providing brief, validated digital tests for memory and executive function. Comparable to LASSI-D as a self-administered digital cognitive assessment with research and clinical applications.
Others
- C2N Diagnostics: C2N Diagnostics develops PrecivityAD, a blood-based biomarker test for Alzheimer's disease detection. Mentioned in I-Function's own positioning as a more expensive alternative; serves the same early-detection clinical use case via a different modality (blood biomarker vs. digital assessment).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
I-Function financial estimates
Financial estimateRevenue estimate
Valuation estimate
I-Function leadership team
Management profileNumber of profiles
Profiles3 records
I-Function funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
I-Function M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about I-Function
What does I-Function do?
I-Function develops and sells cloud-based digital cognitive assessment and functional skills training software for the healthcare market. Its two principal commercial products are LASSI-D, a 15-minute self-administered digital cognitive assessment with AI avatar guidance for early detection of memory impairment associated with Alzheimer's disease, and FUNSAT, a 6-module interactive platform that evaluates and trains everyday functional skills such as online banking, medication management, and transportation.
Is I-Function a public or private company?
I-Function is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was I-Function founded?
I-Function was founded in 2016. It employs 1 to 10 people.
Where is I-Function based?
I-Function is headquartered in Miami, United States, in the North America region.
How does I-Function make money?
Two revenue lines are on record. Assessment Licensing - LASSI-D is the primary driver. The others are training Platform Licensing - FUNSAT.
Who are I-Function's main competitors?
Direct peers on record are BrainCheck, Cognivue, Cambridge Cognition, Cogstate, Neurotrack and Posit Science (BrainHQ). Emerging players are Linus Health, Altoida and Savonix. C2N Diagnostics is listed as an others.
Does I-Function have an API?
No public API is recorded for I-Function.
What industry is I-Function in?
I-Function's product category is Digital Cognitive Assessment Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of EDAFAFAD, Intelligent Practice & Mastery Learning Platforms (Spaced Repetition, Skill Drills). Its NAICS code is 61171 and its SIC code is 7372.